Login / Signup

The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsis.

Matthias GijsenErwin DreesenJoost WautersYves DebaveyeIsabel Spriet
Published in: Intensive care medicine (2022)
Keyphrases
  • study protocol
  • phase iii
  • acute kidney injury
  • intensive care unit
  • clinical trial
  • septic shock
  • phase ii
  • gram negative
  • open label